Literature DB >> 2841949

Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells.

M G Davis1, E S Huang.   

Abstract

The human cytomegalovirus immediate-early gene region 1 promoter-enhancer is active in bacteria and in many mammalian cells. Recombinant plasmids containing portions of this DNA can be used to promote the expression of foreign proteins in many cells. In this communication, we report the optimal conditions for transfer of plasmid DNA to cells by electroporation and the transient expression assays which document the activity of different promoter constructions. The observed activity of the human cytomegalovirus promoter is more than 100-fold higher than the activity of the early promoter of SV40.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841949

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  31 in total

1.  Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.

Authors:  M Carey; J Kolman; D A Katz; L Gradoville; L Barberis; G Miller
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Transcriptional regulatory elements stimulate recombination in extrachromosomal substrates carrying immunoglobulin switch-region sequences.

Authors:  H Leung; N Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  The BFRF1 gene of Epstein-Barr virus encodes a novel protein.

Authors:  A Farina; R Santarelli; R Gonnella; R Bei; R Muraro; G Cardinali; S Uccini; G Ragona; L Frati; A Faggioni; A Angeloni
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina.

Authors:  Roberta Gonnella; Antonella Farina; Roberta Santarelli; Salvatore Raffa; Regina Feederle; Roberto Bei; Marisa Granato; Andrea Modesti; Luigi Frati; Henri-Jacques Delecluse; Maria Rosaria Torrisi; Antonio Angeloni; Alberto Faggioni
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Cooperation of pre-mRNA sequence elements in splice site selection.

Authors:  Z Dominski; R Kole
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

6.  Selection of splice sites in pre-mRNAs with short internal exons.

Authors:  Z Dominski; R Kole
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

7.  Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.

Authors:  Guillaume Collet; Nathalie Lamerant-Fayel; Magdalena Tertil; Bouchra El Hafny-Rahbi; Jacek Stepniewski; Alan Guichard; Alexandra Foucault-Collet; Krzysztof Klimkiewicz; Stéphane Petoud; Agata Matejuk; Catherine Grillon; Alicja Jozkowicz; Jozef Dulak; Claudine Kieda
Journal:  Mol Cancer Ther       Date:  2013-10-29       Impact factor: 6.261

8.  The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.

Authors:  T Ragoczy; L Heston; G Miller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

9.  Activation domain requirements for disruption of Epstein-Barr virus latency by ZEBRA.

Authors:  S Asković; R Baumann
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

10.  Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.

Authors:  J L Kolman; N Taylor; D R Marshak; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.